Antiparasitic effects of gold nanoparticles with microwave radiation on promastigotes and amastigotes of Leishmania major

References

• Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: S305–318
   PubMed Web of Science ®Google Scholar
• Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366: 1561–1577
   PubMed Web of Science ®Google Scholar
• Khatami A, Firooz A, Gorouhi F, Dowlati Y. Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials. J Am Acad Dermatol 2007; 57(335)e1–29
   PubMedGoogle Scholar
• Pourmohammadi B, Motazedian M, Handjani F, Hatam G, Habibi S, Sarkari B. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis. Southeast Asian J Trop Med Pub Health 2011; 42: 502–508
   PubMed Web of Science ®Google Scholar
• Maleki Masoud JZ, Taheri A, Ebrahimirad M. A study of hematologic, hepatic and renal side effects of intramuscular injection of meglumine antimoniate (glucantime) on patients with cutaneous leishmaniasis. Med J Mashhad Univ Med Sciences 2007; 50: 269–274
   Google Scholar
• Berman J. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684–703
   PubMed Web of Science ®Google Scholar
• Davidson RN. Practical guide for the treatment of leishmaniasis. Drugs 1998; 56: 1009–1018
   PubMed Web of Science ®Google Scholar
• Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol 2000; 25: 363–370
   PubMed Web of Science ®Google Scholar
• Nguyen M, Weiss P, LaBarre R, Miller L, Oldfield B, Wallace M. Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans. AIDS 1996; 10: 1745–1747
   PubMed Web of Science ®Google Scholar
• Soto J, Valda-Rodriquez L, Toledo J, Vera-Navarro L, Luz M, Monasterios-Torrico H, et al. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis. Am J Trop Med Hyg 2004; 71: 577–581
   PubMed Web of Science ®Google Scholar
• Gallis HA. Amphotericin B: A commentary on its role as an antifungal agent and as a comparative agent in clinical trials. Clin Infect Dis 1996; 22: 145–147
   Web of Science ®Google Scholar
• Graybill JR. Lipid formulations for amphotericin B: Does the emperor need new clothes?. Ann Intern Med 1996; 124: 921–923
   PubMed Web of Science ®Google Scholar
• Ouellette M, Drummelsmith J, Papadopoulou B. Leishmaniasis: Drugs in the clinic, resistance and new developments. Drug Resist Update 2004; 7: 257–266
   PubMed Web of Science ®Google Scholar
• Berman JD, Neva FA. Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro. Am J Trop Med Hyg 1981; 30: 318–321
   PubMed Web of Science ®Google Scholar
• Sacks DL, Barral A, Neva FA. Thermosensitivity patterns of Old versus New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg 1983; 32: 300–304
   PubMed Web of Science ®Google Scholar
• Neva FA, Petersen EA, Corsey R, Bogaert H, Martinez D. Observations on local heat treatment for cutaneous leishmaniasis. Am J Trop Med Hyg 1984; 33: 800–804
   PubMed Web of Science ®Google Scholar
• Junaid AJ. Treatment of cutaneous leishmaniasis with infrared heat. Int J Dermatol 1986; 25: 470–472
   PubMed Web of Science ®Google Scholar
• Sharquie KE, al-Hamamy H, el-Yassin D. Treatment of cutaneous leishmaniasis by direct current electrotherapy: The Baghdadin device. J Dermatol 1998; 25: 234–237
   PubMedGoogle Scholar
• Aram H, Leibovici V. Ultrasound-induced hyperthermia in the treatment of cutaneous leishmaniasis. Cutis 1987; 40: 350–353
   PubMed Web of Science ®Google Scholar
• Asilian A, Sharif A, Faghihi G, Enshaeieh S, Shariati F, Siadat A. Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis. Int J Dermatol 2004; 43: 736–738
   PubMed Web of Science ®Google Scholar
• Babajev K, Babajev O, Korepanov V. Treatment of cutaneous leishmaniasis using a carbon dioxide laser. Bull WHO 1991; 69: 103–106
   PubMed Web of Science ®Google Scholar
• Meawad OB. Selective heat therapy in cutaneous leishmaniasis: A preliminary experience using the 585 nm pulsed dye laser. J Eur Acad Dermatol Venereol 1997; 8: 241–244
   Web of Science ®Google Scholar
• Rodriguez ME, Inguanzo P, Ramos A, Pérez J. Treatment of cutaneous leishmaniasis with CO2 laser rays. Rev Cubana Med Trop 1990; 42: 197–202
   PubMedGoogle Scholar
• Navin TR, Arana BA, Arana FE, de Mérida AM, Castillo AL, Pozuelos JL. Placebo-controlled clinical trial of meglumine antimonate (glucantime) versus localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg 1990; 42: 43–50
   PubMed Web of Science ®Google Scholar
• Badgwell Doherty C, Doherty SD, Rosen T. Thermotherapy in dermatologic infections. J Am Acad Dermatol 2010; 62: 909–927
   PubMed Web of Science ®Google Scholar
• Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell R, Davies C, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: A randomized, controlled trial. Clin Infect Dis 2005; 40: 1148–1155
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008; 23: 217–228
   PubMed Web of Science ®Google Scholar
• Ghahremani FH, Sazgarnia A, Bahreyni-Toosi MH, Rajabi O, Aledavood A. Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: An in vitro study on osteosarcoma. Int J Hyperthermia 2011; 27: 625–636
   PubMed Web of Science ®Google Scholar
• Sazgarnia A, Zabolinejad N, Layegh P, Rajabi O, Berenji F, Javidi Z, et al. Antileishmanial activity of liposomal clarithromycin against Leishmania major Promastigotes. Iran J Basic Med Sci 2012; 15: 1210–1214
   PubMed Web of Science ®Google Scholar
• Dutta S, Ray D, Kolli BK, Chang KP. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro. Antimicrob Agents Chemother 2005; 49: 4474–4484
   PubMed Web of Science ®Google Scholar
• Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: A placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006; 31: 634–637
   PubMed Web of Science ®Google Scholar
• Levine N. Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol 1992; 128: 759–761
   PubMedGoogle Scholar
• Lobo IMF, Soares MBP, Correia TM, de Freitas LAR, Oliveira MI, Nakatani M, et al. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (glucantime) therapy. Trans R Soc Trop Med Hyg 2006; 100: 642–649
   PubMed Web of Science ®Google Scholar
• Sadeghian G, Nilfroushzadeh M, Iraji F. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol 2007; 32: 371–374
   PubMed Web of Science ®Google Scholar
• Velasco-Castrejon O, Walton B, Rivas-Sanchez B, Garcia M, Lazaro G, Hobart O, et al. Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg 1997; 57: 309–312
   PubMed Web of Science ®Google Scholar
• Willard RJ, Jeffcoat AM, Benson PM, Walsh DS. Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J Am Acad Dermatol 2005; 52: 977–987
   PubMed Web of Science ®Google Scholar
• Wortmann G. Boiling the boil. Clin Infect Dis 2005; 40: 1156–1158
   PubMed Web of Science ®Google Scholar
• Falk M, Issels R. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
   PubMed Web of Science ®Google Scholar
• Wust P, Seebass M, Nadobny J, Deuflhard P, Mönich G, Felix R. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int J Hyperthermia 2009; 25: 517–528
   PubMed Web of Science ®Google Scholar
• Franconi C, Vrba J, Micali F, Pesce F. Prospects for radiofrequency hyperthermia applicator research. I: Pre-optimised prototypes of endocavitary applicators with matching interfaces for prostate hyperplasia and cancer treatments. Int J Hyperthermia 2011; 27: 187–198
   PubMed Web of Science ®Google Scholar
• Asilian A, Iraji F, Hedaiti H, Siadat A, Enshaieh S. Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): A case series of 24 patients. Dermatol Online J 2006; 12(2)3
   PubMedGoogle Scholar
• Ghaffarifar F, Jorjani O, Mirshams M, Miranbaygi M, Hosseini Z. Photodynamic therapy as a new treatment of cutaneous leishmaniasis. East Mediterr Health J 2006; 12: 902–908
   PubMedGoogle Scholar
• Sohl S, Kauer F, Paasch U, Simon JC. Photodynamic treatment of cutaneous leishmaniasis. J German Soc Dermatol 2007; 5: 128–130
   PubMedGoogle Scholar
• Van Der Snoek E, Robinson D, Van Hellemond J, Neumann H. A review of photodynamic therapy in cutaneous leishmaniasis. J Eur Acad Dermatol Venereol 2008; 22: 918–922
   PubMed Web of Science ®Google Scholar
• Kosaka S, Akilov OE, O'Riordan K, Hasan T. A Mechanistic study of δ-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. J Investig Dermatol 2007; 127: 1546–1549
   PubMed Web of Science ®Google Scholar
• Jafari Parizi A, Sazgarnia A, Layegh P, Rajabi O. Cytotoxicity and phototoxicity of chlorophyll a/hydroxypropyl-γ-cyclodextrin complex on Leishmania major promastigotes. Iranian J Med Phys 2011
   Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49: N309–315
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005; 11: 3530–3534
   PubMed Web of Science ®Google Scholar
• Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnol 2008; 6
   PubMedGoogle Scholar
• Hanson G, Monreal R, Apell SP. Electromagnetic absorption mechanisms in metal nanospheres: Bulk and surface effects in radiofrequency-terahertz heating of nanoparticles. J Appl Phys 2011; 109: 124306–124312
   Web of Science ®Google Scholar
• Li D, Jung YS, Tan S, Kim HK, Chory E, Geller DA. Negligible absorption of radiofrequency radiation by colloidal gold nanoparticles. J Colloid Interface Sci 2011; 358: 47–53
   PubMed Web of Science ®Google Scholar
• Alzate J, Barrientos AÁ, Gonzalez V, Jimenez-Ruiz A. Heat-induced programmed cell death in Leishmania infantum is reverted by Bcl-X L expression. Apoptosis 2006; 11: 161–171
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Corry PM. Commentary on classic paper in hyperthermic oncology “Tumour oxygenation is increased by hyperthermia at mild temperatures” Song, CW et al 1996. Int J Hyperthermia 2009; 25: 96–98
   PubMed Web of Science ®Google Scholar